Home
Corporate
Operations
- R & D
- Project Portfolio
- Our projects
  - Xerclear
  - TMC435
  - HCV POL
  - MIV-710 Cathepsin K
  - MIV-711 Cathepsin K
  - HIV PI
  - BACE
  - Cathepsin S
  - COPD
  - Renin
  - Valomaciclovir
  - Alovudine
  - Lagociclovir
  - MIV-150
  - MIV-160
  - MIV-410
- Technologies
- Patents
IR & Media
Career and Contact
Search

MIV-150

Therapy Area
A NNRTI HIV as vaginal microbicide in combination with Carraguard® (PC815) to protect women against HIV infection.

Competitive Edge
Broad activity and excellent safety profile. No effective product on the market.

Licensee
Population Council, New York.

Last Modified: 12/05/2009